The emerging Make America Healthy Again (MAHA) movement has resurrected the well-worn accusation that food and drug companies dictate U.S. public health policy. How true is this claim? And do the leaders of the MAHA campaign have their own conflicts of interest? They sure do.
Join Cameron English and Dr. Chuck Dinerstein on Episode 93 of the Science Dispatch podcast as they discuss:
Calley Means, co-founder of TruMed, recently raised concerns about conflicts of interest within the FDA and the influence of corporate funding on public health guidelines. Thereby, he joined the ranks of Robert F. Kennedy, Jr and his newfound friend, former President Trump, who argued for "a special Presidential Commission of independent minds who are not bought and paid for by Big Pharma."
Listen to the Science Dispatch on iTunes Spotify, Stitcher and Google Podcasts. Or add the RSS feed to your favorite podcast app. Join our Dispatch newsletter to get these stories and more delivered to your inbox.
Category